I switched to Inflectra

TODAYS THE DAY! I’m getting my first dose of INFLECTRA (Pfizer's biosimilar to Remicade).

At the start of 2020 the government announced that coverage was changing for people who take Remicade® (infliximab) for the treatment of Crohn’s disease or ulcerative colitis. This meant that patients receiving the biologic drug infliximab, marketed as Remicade®, would see this coverage discontinue with new coverage for the biosimilar version: Inflectra and Renflexis.

Come into my infusion with me, as my nurse, Erica explains everything that’s going on and how it differs from Remicade.

Dive in with me to learn about:
Why I switched to Inflectra
What is a biosimilar?
Why do we have to switch?
Why is there a huge pushback on switching?
Why am I okay with this?
_________

00:00 - Infusion day!
00:19 - A little background
00:33 - Why am I switching to Inflectra?
01:35 - Pushback on switching
02:17 - Why am I okay with switching?
02:42 - THE INFUSION
04:02 - Mixing the INFLECTRA
07:51 - Post infusion
08:33 - What is a Biosimilar?
09:32 - Outro

_________

🔔 Subscribe for more! ➡️    / @effiesiamalekas  

WATCH 🎥 MY LIFE WITH UC | My Remicade infusions ➡️    • MY LIFE WITH UC | My Remicade infusions  

WATCH 🎥 Ulcerative Colitis: My Story ➡️    • Ulcerative Colitis: My Story  

WATCH 🎥 MY LIFE WITH UC | What Is Ulcerative Colitis? ➡️    • MY LIFE WITH UC | What Is Ulcerative ...  


______

🎬 My Photo & Video Company: 🎬
https://effieedits.com/

For all the behind-the-scenes of my life and business, make sure to follow my Instagram Stories over @EffieEditsPhoto @Effie_Christina ➡️
  / effieeditsphoto  
  / effie_christina